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Summary
The coronary collateral circulation provides an alternative
source of blood supply to myocardium jeopardised by
ischaemia. Collaterals enlarge with obstructive coronary
artery disease to allow bulk flow, but blood flow deliver-
able by the native, pre-formed collateral extent can already
be sizeable. Genetic determinants contribute significantly
to the wide variability observed in both native collateral
extent and its capacity to enlarge, and the severity of the
coronary stenosis is the most significant environmental de-
terminant for collateral enlargement. The protective effect
of a well-developed coronary collateral circulation trans-
lates into relevant improvements in all-cause and cardiac
mortality in the acute and chronic phases of coronary artery
disease, as well as into a reduction of future adverse cardi-
ovascular events.
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Introduction
Coronary collaterals are cross-connections between coron-
ary arteries, which are present regardless of coronary artery
disease (CAD) [1]. As natural bypasses, coronary collater-
als provide an alternative source of blood flow to a myocar-
dial area when normal antegrade supply is compromised.
In the presence of arterial stenoses, the process of collateral
remodelling leads to a gradual calibre increase of the col-
lateral vessels, allowing the effective delivery of bulk flow
to jeopardised tissue [2]. Conversely, the collateral network
in the absence of obstructive coronary artery disease rep-
resents the native collateral circulation, pre-existing in the
absence of coronary narrowing. Contrary to popular belief,
blood flow deliverable by native collaterals can be sizeable
[3]. The relevance of the coronary collateral circulation be-
comes eminent in CAD, which remains a leading cause
of death globally [4]. In acute coronary occlusion, the ex-
tent of collateral pathways is a significant determinant of
the severity of myocardial infarction [5–8]. In the chronic
phase of CAD, the collateral circulation variably com-
pensates for the flow-limiting features of atherosclerosis,
i.e., stenotic lesions.
The purpose of this article is to give a concise review of the
salient features of the coronary collateral circulation and
provide an overview of its assessment and clinical relev-
ance.
Coronary collateral dynamics
The dynamics of the coronary collateral circulation are
governed by the physical laws of pressure and flow [9]. In
the native collateral network, there is an oscillatory move-
ment of blood, as it is fed from opposing directions [1, 10].
Thus, there is typically little to no net blood flow, as blood
moves to-and-fro along the length of the collateral circu-
lation, which prevents haemostatic thrombosis. Effective
flow across collaterals to jeopardised myocardium is in-
duced when normal antegrade blood supply is comprom-
ised – the collaterals are recruited (fig. 1).
Figure 1
Lifecycle of the collateral circulation. The native collateral extent in
the adult is determined by its formation in embryonic
collaterogenesis (top right). Blood moves to and fro in native
collaterals, while effective flow is recruited by acute obstruction.
With continued obstruction, there is collateral enlargement, which
occurs independent of ischaemia. Neocollateral formation has been
suggested in chronic obstructive disease, whereas experimental
studies have shown collateral rarefaction with aging.
(Data from Faber JE, et al. A brief etymology of the collateral
circulation. Arterioscler Thromb Vasc Biol. 2014;34:1854–9 [1], with
permission.)







































Regulation of collateral growth independent of
ischaemia
Alterations in blood flow and blood pressure are the key
regulators of the adaptive process in recruited collaterals,
known as remodelling. A haemodynamically significant
coronary stenosis reduces coronary perfusion pressure
distal to the narrowed segment as a result of energy losses.
Autoregulation maintains basal flow distal to the stenosis
by microvascular vasodilation up to a critical reduction in
vessel lumen area, beyond which resting coronary blood
flow is also reduced [11]. Concurrently, the pressure drop
across the stenosis leads to a pressure gradient along the
pre-existing collaterals connecting to the constricted ves-
sel, leading to their recruitment: effective flow is induced
from the donor artery across the collateral network to the
recipient coronary artery. Heightened flow velocity leads to
a proportional increase in fluid shear stress (FSS), whereas
the increased intravascular pressure leads to a proportional
increase in circumferential wall stress (CWS) [3, 12]. With
a prolonged stimulus, the collateral network reacts by in-
creasing the lumen diameter to normalise FSS and by in-
creasing the wall thickness to normalise CWS [13].
Range of adaptation of collaterals
The term arteriogenesis was introduced to differentiate
growth of pre-existing collaterals from angiogenesis,
which is triggered by ischaemia [12, 14]. Blood flow can
increase maximally 10- to 20-fold by arteriogenesis, but
only 1.5- to 1.7 fold by angiogenesis, which refers to the
sprouting of new, minute, high-resistance, low-flow capil-
laries [13]. To generate the same lumen area as the artery
by angiogenesis would in essence mean replacing the organ
with capillaries – with the end result of a haemangioma
[13, 15]. Thus, arteriogenesis has the capacity to com-
pensate for an occluded artery, whereas angiogenesis does
not [12, 16].
Even though mature collaterals are able to deliver bulk
flow to jeopardised tissue, collateral remodelling stops
short of completely reconstituting the function of an oc-
cluded artery [17, 18]. Primarily responsible for this cir-
cumstance is the premature normalisation of the dominant
driving force for continued outward remodelling – flow-in-
duced fluid shear stress. Even a small increase in luminal
diameter leads to a much larger fall in FSS, a consequence
of FSS being inversely related to the third power of the ves-
sel radius. In physiological circumstances, normal maxim-
al blood flow is, therefore, not achievable even in healthy
collateral-dependent tissues [19]. Conversely, a complete
functional reconstitution, even surpassing normal maximal
function, is achieved when FSS is artificially increased [17,
18, 20, 21].
Collateral remodelling and its relation to the phases of
coronary artery disease
Collateral remodelling is a mitotic process which takes two
to three days before a relevant increase beyond the acutely
recruitable blood flow begins to occur [2, 3, 16, 22]. The
proliferation of endothelial and smooth muscle cells with
perivascular gathering of bone marrow derived cells (not-
ably macrophages and T cells) is followed by controlled
destruction of the collateral vessel to build a new scaffold
for the much larger vessel [3]. In the process of many re-
modelling collateral connections, a larger diameter in some
collaterals presents an advantage in the ensuing competi-
tion for flow. As a consequence, only a few collaterals ul-
timately reach maturation, while many others are closed by
an overshoot of intimal proliferation – a process known as
pruning [2, 23].
In patients with chronic total occlusion (CTO), collateral
function improves over a time period of 12 weeks after oc-
clusion [24], which is in line with observations in experi-
mental studies [25]. The collateral remodelling in these pa-
tients typically relates to chronic stable CAD in a setting of
a more or less gradual progression of coronary obstruction,
which allows sufficient time for the growing collaterals to
preserve myocardial viability.
In patients with acute coronary occlusion, the timeframe
for insufficient collaterals to remodel (further) is generally
too short. Plaque rupture is the most common cause of
acute coronary syndromes, which, when followed by ath-
erothrombosis, leads to rapid and insidious thrombotic oc-
clusion [26]. In this context, it is of note that most of the
coronary lesions ultimately responsible for major adverse
cardiovascular events (MACE) have been shown to be an-
giographically mild [27]. Therefore, the culprit lesion itself
is unlikely to cause relevant collateral remodelling [27–29].
In the absence of stenosis-induced enlargement, the pro-
tective effect from acute ischaemia is entirely dependent on
the extent of the native collateral network. Therefore, the
notion of the native collateral circulation is pertinent not
only in the healthy state, but also in coronary artery disease
(CAD).
Notably, myocardial viability is not a prerequisite for the
remodelling of coronary collaterals [31, 32]. Thus, well-de-
veloped collaterals can be observed to grow only after its
dependent myocardium has become entirely necrotic, again
consistent with the notion that collateral growth can occur
independently of ischaemia.
Genetic and environmental
determinants of the coronary
collateral circulation
The wide interindividual variability in coronary collaterals
is evident not only with regard to the preformed extent, but
also with regard to its capacity to remodel. Specifically, the
extent of native collaterals relates to the formation and mat-
uration of collaterals in early life [30], whereas collateral
remodelling takes place generally much later (most often
under the influence of coronary obstruction). In experi-
mental studies, the use of different animal models permits
these aspects to be studied also in healthy tissues, which al-
lows genetic factors to be separated from environmental in-
fluences. Conversely, the protective role of collaterals be-
comes eminent chiefly in CAD, the risk of which increases
with the number and severity of cardiovascular risk factors.
Accordingly, the impact of the risk factors predisposing to
atherosclerosis has to be considered, too [31].
Severity of coronary obstruction
The presence of a haemodynamically significant stenosis is
the sine qua non for the calibre increase of collaterals in
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remodelling. The severity of the flow impediment dictates
the pressure drop, which in turn determines the amount of
shear stress in recruited collaterals, with higher shear stress
leading to more pronounced remodelling. Consequently, in
patients with CAD, the severity of the underlying arterial
obstruction has been found to be the only independent pre-
dictor for good collateral function [32, 33]. Furthermore,
collateral flow was found to be higher in CTO than in
nonocclusive obstructions [24, 34–38].
The effect of continued remodelling is well illustrated by
the frequency distributions of collateral function with in-
creasing severity of the underlying CAD (fig. 2) [32, 39,
40]. Although sufficient collaterals are already present in a
significant minority of patients with angiographically nor-
mal coronary arteries [39], with CAD there is a rightward
Figure 2
Frequency distribution (vertical axes in percent) of collateral flow
index (CFI, horizontal axes) in patients without coronary artery
disease (CAD; top left) and with increasing severity of CAD.
Sufficient collaterals by CFI are present in a fourth of patients with
angiographically normal coronary arteries, whereas this proportion
increases to one third in patients with CAD.
(Data from Meier P, et al. Beneficial effect of recruitable collaterals:
a 10-year follow-up study in patients with stable coronary artery
disease undergoing quantitative collateral measurements.
Circulation. 2007;116:975–83 [40], with permission.)
Figure 3
Frequency distribution (vertical axis in percent) of collateral flow
index (CFI, horizontal axis) in 295 patients with chronic total
occlusion. In this population mean CFI was 0.39 ± 0.14.
(Adapted from van der Hoeven NW, et al. Clinical parameters
associated with collateral development in patients with chronic total
coronary occlusion. Heart. 2013;99:1100–5 [38], with permission
from BMJ Publishing Group Ltd.)
shift of the near-Gaussian distribution, which increases
from one- to three-vessel disease and is most pronounced
in CTO (fig. 3) [40]. However, there is still considerable
interindividual variability in the level of collateral function
for a given stenosis severity, which highlights the modula-
tion of the arteriogenic response by other factors [36].
Determinants of coronary collateral supply in the
absence of remodelling
The structural extent of native collaterals varies signific-
antly between individuals, with respect to both number and
average diameter [41]. Likewise, in healthy human sub-
jects, invasively determined collateral function varies by
10-fold in the absence of angiographically detectable CAD
[32, 40].
A plausible explanation for this marked variation is the lack
of selective pressure in the genetic background underlying
native collateral extent, which relates to genes that con-
trol formation and maturation of collaterals [30, 42, 43].
In other words, redundancies that compensate for signific-
ant changes in expression of collateralogenic genes have
not evolved because the protective effects are needed only
well after the peak reproductive years [44]. In experimental
studies, significant advances have been made with regard
to the genetic architecture underlying variation in the ex-
tent of the collateral circulation [43]. A substantial amount
of the variability appears to arise from naturally occurring
polymorphisms in genetic loci directing the formation of
the collateral circulation [30, 43, 45]. In particular, a quant-
itative trait locus predominantly affecting native collateral
number and diameter has been identified in mice [43]. In
the same context, several genes showed differential expres-
sion for well versus poorly developed collateral function in
patients with no angiographically significant CAD [46].
Although the genetic determinants appear to have a major
influence on the extent of native collaterals, clinical vari-
ables have also been identified. In patients free of coronary
stenosis, multivariable regression analysis with inclusion
of 39 clinical test variables notably showed that bradycar-
dia (not related to beta-blockers) and absence of arterial hy-
pertension were independent positive predictors for collat-
eral function [47].
Determinants of arteriogenic response
As mentioned previously, differences in the genetic back-
ground for collateral formation and maturation contribute
significantly to the considerable interindividual variation in
the pre-existing collateral extent [48]. By the same token,
another genetic pathway has been found to significantly de-
termine the remodelling capacity of the native collateral
extent [43]. Similarly, marked variability has also been ob-
served in the arteriogenic response, that is, the extent of
remodelling. This is well illustrated by experimental stud-
ies where, although the arteriogenic stimulus in the form
of total vascular occlusion is kept as a constant, the arteri-
ogenic response has been found to vary substantially even
in same strains. In humans, gene expression analysis has
shown that a distinct genetic profile in monocytes relates to
quantitatively determined collateral function in obstructive
CAD [46].
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Apart from the marked variability in both native collateral
extent and capacity to remodel, another consistent finding
is that a poor arteriogenic response is also associated with
poor native collateral extent [17, 46, 47]. Indeed, animals
with poor pre-existing collaterals reach significantly lower
levels of collateral function after arterial occlusion com-
pared with animals with good pre-existing collaterals both
within, as well as between, strains. Although this obser-
vation may be consistent with a genetic link influencing
both maturation and remodelling of collaterals, such an as-
sociation has not been found. Then again, on a conceptu-
al basis, such an assumption appears superfluous, given the
plausibility that the pre-existing collateral extent presents a
limiting factor for its enlargement in remodelling. In other
words, a poor native collateral circulation itself appears to
be a limiting factor for its later positive remodelling, in that
the extent of flow recovery reaches levels inferior to that
from a rich native collateral network [48]. Thus, the pre-
existing collateral extent determines critically the degree of
protection from ischaemic injury not only in the absence,
but also in the presence of collateral remodelling, in that
it also governs the capacity for outward remodelling in the
latter [16, 48–51].
Influence of traditional cardiovascular risk factors
In the majority of cases, coronary atherosclerosis coincides
with one or more cardiovascular risk factors. Given that en-
dothelial dysfunction is a well-established response to car-
diovascular risk factors, it is conceivable that the collateral
circulation might equally be affected. Notably though, col-
lateral arteries and arterioles do not seem prone to athero-
sclerosis [6].
Dyslipidaemia has been shown to hamper arteriogenesis in
hyperlipidaemic experimental models [52, 53]. Contrarily,
no evidence exists for such an effect in humans: dyslipid-
aemia has not been found to be an independent predictor
for quantitatively determined collateral function in patients
with or without CAD [32]. Furthermore, in a large clinical
study in patients with CAD, no effect of statins on coronary
collateral function was found [54].
Arterial hypertension is reflected in the tortuosity and en-
larged calibre of arteries, secondary to an adaptive response
to increased shear stress [55]. Two clinical studies in pa-
tients with obstructive CAD found conflicting results in
this regard, but both were limited in that occlusion of the
collateral-receiving artery was not uniformly present or
performed for appropriate angiographic assessment [56,
57]. In patients with CTO with quantitatively assessed col-
lateral function, hypertension was a predictor for better de-
veloped collaterals in a multivariate analysis. In the human
heart without CAD, the contrary has been found to be true:
better collateral function in the absence of arterial hyper-
tension [47].
Increasing age is a well-known risk factor for atheroscler-
osis. Structural alterations with advancing age are accom-
panied by a decline in vascular function [58]. However, its
impact on the collateral circulation is equivocal. Experi-
mental studies have documented a decline in structural ex-
tent of pre-existing collaterals, which is compounded by re-
duced remodelling [51]. A possible mechanism has been
suggested to be the unique haemodynamic environment
with oscillatory shear stress that could predispose the col-
lateral circulation to accelerated aging compared with the
general circulation. Alternatively, or in addition, impaired
endothelial nitric oxide signalling, deemed to be an im-
portant factor for maintenance of collateral density, as well
as remodelling in obstructive disease, has been implicated
in the increased propensity of endothelial cells to under-
go apoptosis and thereby cause collateral rarefaction [51,
59]. Clinically, a causal link between increased mortality of
elderly individuals in acute myocardial infarction and re-
duced collateral extent could be supported by the inverse
relation between age and the level of angiographic collat-
eral extent seen in these patients [60, 61]. However, the
clinical association of higher mortality in ischaemic cardi-
ovascular disease and poorly developed collaterals has not
been shown to be independent. In a univariate analysis of a
large database including quantitatively determined collater-
al function, only a trend towards the described inverse rela-
tion was seen [37]. Furthermore, in a pooled analysis of pa-
tients with a CTO and quantitatively determined collateral
function, an association between higher age and poorly de-
veloped collaterals could not be confirmed [38]. In essence,
although experimental data are consistent with an age-asso-
ciated decline in collateral extent and remodelling, on bal-
ance, age is probably not a major determinant of collateral
function in humans.
No differences have been found in quantitatively determin-
ed collateral function among matched patients with versus
without diabetes in angiographically normal or diseased
coronary arteries [62]. Furthermore, in a patient cohort
with CTO, a multivariate analysis confirmed these findings
[38]. Earlier controversies in this context are likely at-
tributable to the above-mentioned methodical flaw in an-
giographic assessment [63–65].
Assessment of the coronary collateral
circulation
An accurate assessment of the coronary collateral circula-
tion requires normal antegrade and collateral blood flow
to be distinguished. In the absence of a coronary stenosis
there is essentially no measurable net blood flow across
pre-formed, but not recruited collaterals. Conversely, in the
presence of nonocclusive disease, the contribution of nor-
mal antegrade blood flow cannot be differentiated from the
recruited blood flow via the anastomotic pathways. There-
fore, for exclusive characterisation of recruitable collater-
al blood flow, (transient) coronary occlusion is required,
regardless of the method employed [66, 67]. Accordingly,
noninvasive imaging techniques are limited to the re-
modeled collateral circulation supplying chronic total
coronary occlusions [66]. Conversely, invasive techniques,
i.e., during coronary catheterisation, permit an assessment
of both the native and remodelled collateral circulation.
Different modalities allow evaluation of the ischaemia-
abating function of coronary collaterals. Abnormalities in
distribution and quantity of myocardial blood flow are the
earliest pathophysiological events in myocardial ischaemia
[67]. Imaging techniques that measure perfusion are there-
fore most distinctive in collateral assessment, given that
sufficient collaterals may prevent even stress-induced ab-
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normalities occurring later in the ischaemic cascade [68].
Only a critical reduction in perfusion leads first to an
impairment of diastolic, then of systolic function, followed
by electrocardiographic (ECG) changes and ultimately by
symptomatic expression (angina pectoris).
Commonly employed imaging techniques that delineate
coronary anatomy allow only a very limited structural as-
sessment of coronary collaterals, given that most collaterals
are below their spatial resolution and therefore go undetec-
ted.
Noninvasive assessment
Clinically, myocardial perfusion and wall motion function
are measurable notably by (myocardial contrast) echocardi-
ography (MCE) [69], positron emission tomography (PET)
[66, 70], single-photon emission computed tomography
(SPECT) [71], cardiac magnetic resonance imaging (CMR)
[72], and cardiac computed tomography (CT). Preservation
of perfusion and, consequently, wall motion function [73]
vary as a function of the underlying collateral supply and
the extent and degree of coronary lesions. Similarly, for
a given lesion severity, there is a continuum from a com-
pletely normal ECG under stress conditions to transient,
chronic and acute repolarisation abnormalities [74]. It fol-
lows from the above considerations that collateral assess-
ment by noninvasive techniques is most distinctive in the
presence of total coronary occlusion. In nonocclusive
Figure 4
Immersion radiography of an ex vivo arteriogram of a normal
human heart. Tissue shadows are almost eliminated by immersion
of the specimen in saline. Blood vessels are radiologically
demonstrated to 20 µm, a spatial resolution sufficient to reproduce
the dense collateral network, over which retrograde filling of the
branch of the left circumflex coronary artery doubly ligated (arrow)
before contrast injection occurs. In contrast, coronary angiography
does not detect the majority of anastomotic vessels due to its
inferior spatial resolution.
(Data from Fulton WF. Immersion radiography of injected
specimens. Br J Radiol. 1963;36:685–8 [121], by permission of the
Oxford University Press.)
CAD, the quality of collaterals can be gauged when com-
paring the extent of anatomical CAD against the observed
functional consequences, i.e. the ischaemic burden. With
acute coronary occlusion, a noninvasive estimate of the
myocardium at risk is typically practicable only with the
ECG [74].
Noninvasive coronary angiography is feasible with coron-
ary CT angiography (CCTA) and coronary MR angio-
graphy. Compared with invasive coronary angiography, the
spatial and temporal resolution achievable by these tech-
niques remain considerably lower [75], essentially render-
ing them unsuitable for structural evaluation of coronary
collaterals [76–78].
Angiographic assessment
The qualitative angiographic methods include the often-
employed Rentrop score and the more recently introduced
collateral connection (CC) grading [79, 80]. The limitation
inherent to collateral assessment with angiography lies in
the restricted spatial resolution, which means that the ma-
jority of the anastomotic vessels remain undetected (fig. 4)
[41, 81]. In addition, angiography assesses only structural
qualities, from which conclusion of functional properties is
notoriously imprecise, even more so in view of the above
constraints [82].
For proper angiographic assessment, occlusion of the
collateral-receiving artery either spontaneously, or by bal-
loon inflation, is mandatory, even when some angiographic
contrast filling of collaterals is already spontaneously
present [66]. Furthermore, proper assessment by the an-
giographic method usually requires a double intubation
technique to allow injection of contrast agent in the pre-
sumable (ipsi- and/or contralateral) donor artery and place-
ment of an occluding balloon in the recipient artery.
However, in clinical practice and even in clinical studies,
balloon occlusion is rarely performed when occlusion is
not spontaneously present, which lowers the sensitivity of
the already blunt method. Obviously, lesser stenoses are
ipso facto associated with absence of angiographic visibil-
ity of collaterals, whereas collaterals are preferentially vis-
ible with more severe stenoses. Thus, a systematic bias
is introduced, where the extent of CAD confounds the
grade of collateral supply. To exaggerate the point, the an-
giographic visibility of collaterals, when natural or transi-
ent artificial occlusion is not present, is more an indicator
of the severity of the stenosis, than of the quality of the col-
laterals [33, 83, 84].
With the Rentrop score, absent contrast filling of collateral
connections or up to the side-branch of the recipient artery
denote insufficient collaterals (score of 0 and 1, respect-
ively), while contrast filling of the epicardial main branch
of the recipient artery, either partial (score of 2), or com-
plete (score of 3) indicate sufficient collaterals. Although
the Rentrop score shows (albeit moderate) correlation with
functional collateral measures, it has relevant shortcom-
ings. A major limitation is the inability of the Rentrop
score to assess adequately the functional significance, i.e.
the protective effect, especially of recruitable, but not spon-
taneously present collateral vessels [33]. Furthermore, in
CTO, the Rentrop grading lacks further differentiation, as
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collaterals are predominantly of Rentrop grade 3 in this set-
ting [80].
The CC score was evaluated in patients with CTO and its
applicability in nonocclusive lesions has so far not been es-
tablished [80]. Collaterals are evaluated according to the
presence of a continuous connection between donor and
recipient artery: CC0, no continuous connection between
donor and recipient artery; CC1, continuous, threadlike
connection; and CC2, continuous, small side branch–like
size of the collateral throughout its course [80]. Regarding
the clinical relevance of the CC grading, in patients without
prior Q-wave myocardial infarction, the regional wall mo-
tion was best preserved with grade CC2 collaterals [80].
Furthermore, the CC score was closely associated with in-
vasively determined parameters of collateral haemodynam-
ics [80].
Instead of angiographic grading, assessment of collaterals
by means of the semiquantitative washout collaterometry
relies on the time to clearance of contrast medium trapped
by balloon occlusion [85]. It correlates well with invasively
determined collateral function and distinguishes accurately
between sufficient and insufficient collaterals [86].
Functional assessment
In contrast to the ordinal angiographic scores, functional
assessment allows quantification of collateral pathways on
a continuous scale. Apart from noninvasive imaging tech-
niques in the setting of a CTO, direct myocardial perfusion
can be measured only during invasively performed tempor-
ary coronary occlusion with quantitative myocardial con-
trast echocardiography (MCE) [69].
Invasively determined, quantitative measures of collateral
function rely on determination of distal coronary pressure
or flow velocity signals [87]. To this purpose, a coronary
guide wire, equipped with a pressure and/or Doppler sensor
near its tip, is positioned distally in the coronary of interest.
The normal antegrade flow is thereafter temporarily
blocked, either during therapeutic coronary angioplasty or
diagnostic balloon occlusion at low inflation pressure, the
acute and long-term safety of which has been confirmed
[88]. Distal coronary occlusive pressure (Poccl) is then set
in relation to aortic pressure measured via the angioplasty
guide catheter, both corrected for the back pressure, rep-
resented by central venous pressure (CVP), to derive the
pressure-derived collateral flow index (CFI, fig. 5) [87].
Similarly, distal flow velocity during coronary occlusion is
compared with resting flow velocity when normal anteg-
rade flow has been restored, to derive velocity-derived CFI
[87]. Pressure signals can be reliably obtained and are ro-
bust to influences such as vessel anatomy, whereas Doppler
signals are prone to wall-motion artifacts and registration
of optimal signals is often not achievable [86, 87].
Pressure-derived CFI has been shown to correlate closely
to myocardial perfusion during balloon occlusion as as-
sessed by perfusion imaging and quantitative myocardial
contrast echocardiography (MCE) [89]. The limitation that
beyond a critical level of left ventricular filling pressure,
Poccl is determined solely by this transmural force and no
longer by collateral driving pressure, applies in acute
myocardial infarction, but infrequently in the setting of
stable CAD [90]. Currently, pressure-derived CFI measure-
ment is the gold-standard for collateral assessment.
In a strict sense, sufficient collaterals have been defined
as those preventing signs of myocardial ischaemia in the
very sensitive intracoronary ECG during coronary (bal-
loon) occlusion [91]. In this context, a pressure-derived
CFI ≥0.217 best detects sufficient collateral supply [92]. In
other words, a collateral supply amounting to more than
22% of normal antegrade flow is sufficient to prevent
myocardial ischemia under resting conditions, a finding
supported by a study performed with single photon emis-
sion tomography among patients with acute myocardial in-
farction before revascularisation [93].
Clinical relevance of the coronary
collateral circulation
The clinical relevance of the coronary collateral circulation
relates to the beneficial effect of well-developed collaterals
in preserving viability and function of dependent myocar-
dium in the context of the acute and chronic manifestations
of CAD. On the other hand, there are also drawbacks,
which manifest preferentially in the presence of a well-de-
veloped collateral network.
Coronary steal
The microvascular resistance in the coronary territory
distal to a coronary obstruction is reduced to keep resting
myocardial blood flow constant. Therefore, in obstructive
coronary disease, an uneven distribution of microvascular
resistances develops, which forms the basis of coronary
steal. The dilatory reserve in an affected territory decreases
with increasing severity of the coronary stenosis and be-
comes exhausted at a critical point when demand is in-
creased, such as occurs with exertion. Consequently, the
flow provided to the obstructed region by antegrade (if
any) and collateral inflow becomes maximal. In this situ-
ation collateral inflow becomes entirely pressure-depend-
Figure 5
Functional collateral assessment by use of pressure-derived
collateral flow index (CFI) during a 1-minute coronary balloon
occlusion. Distal occlusive pressure (Poccl, mm Hg;) is set in relation
to the effective perfusion pressure, aortic pressure (Pao, mm Hg;),
after correction for the back pressure, central venous pressure
(CVP, mm Hg;). Marked ST-segment elevation in the intracoronary
ECG demonstrates collateral function insufficient to prevent
myocardial ischaemia at a CFI = 0.148.
(Reproduced from Seiler C, et al. Prognostic relevance of coronary
collateral function: confounded or causal relationship? Heart.
2013;99(19):1408-14 [5], with permission from BMJ Publication
Group Ltd.)
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ent, as microvascular resistance cannot be further reduced.
Any further reduction in the microvascular resistance in
the collateral-donor territory will consequently reduce the
pressure gradient driving the collateral inflow. Collateral
inflow and with it the net flow is reduced beyond a critical
level of hyperaemia, and myocardial ischaemia precipit-
ated. Coronary flow to a myocardial region during hyper-
aemia that decreases below its resting level consequently
constitutes coronary steal [94–96].
Experimental and clinical studies have shown that coronary
steal is facilitated by a coronary stenosis in the collateral
donor artery and well-developed collaterals. A prevalence
of coronary steal in 10%–20% of patients with nonocclus-
ive CAD [97] and a third to a half in patients with a CTO
demonstrates the relevance of this phenomenon [98–100].
Clinically, coronary steal can be suspected when ischaem-
ic symptoms can be worsened or provoked by vasodilators,
such as nifedipine [65, 66].
Regression of collateral flow and risk of restenosis
after percutaneous coronary intervention
Percutaneous coronary intervention (PCI) of a coronary
stenosis removes its associated resistance to antegrade
coronary flow. Concurrently, the pressure gradient across
the collateral network driving effective collateral flow is
also diminished. In line with the experimental findings
[101–103], clinical studies have accordingly shown a re-
gression of collateral function over time after revascular-
isation [35, 104–106]. Moreover, it has been shown that
recanalisation of occlusive lesions was associated with a
greater decrease in collateral function immediately after re-
vascularisation compared with nonocclusive lesions [104].
Consistent with prior findings, collateral function was sig-
nificantly higher with occlusive than nonocclusive CAD.
Furthermore, in patients with nonocclusive lesions, a col-
lateral recruitment could be seen with the second balloon
inflation (performed immediately after stent implantation),
while patients with a CTO showed acute collateral dere-
cruitment [104, 106]. In the months following revascular-
isation, a further decrease in collateral function could be
observed in patients without reocclusion [35, 106]. Not-
ably, at 6 months follow-up, only 4% of patients with sub-
total or total occlusions at baseline showed sufficient col-
laterals [35], whereas this was observed in 18% of patients
exclusively with a CTO after a mean of 5 months [106].
Incidentally, 10% of patients showed reocclusion after PCI
of a CTO; in these patients collateral function was not dif-
ferent at follow-up when compared with the baseline value.
Also in the context of prior studies [107, 108], an associ-
ation between well-developed collateral function and a risk
for restenosis or reocclusion is conceivable: the sizeable
collateral flow especially after PCI for a CTO could com-
pete with restored antegrade flow and predispose to stent
restenosis in a process similar to atherosclerosis [100, 101].
In view of rather inconsistent findings in prior studies, the
impact of the collateral circulation on the risk for restenosis
has recently been determined in a meta-analysis, integrat-
ing a total of seven studies with angiographic or function-
al collateral assessment [109]. Across studies, good col-
laterals were predictive for restenosis, with a relative risk
increase of 40% (95% confidence interval 1.09‒1.80, p =
0.009).
Protective effect of the coronary collateral circulation
The partly contradictory results regarding the protective ef-
fect of coronary collaterals are chiefly related to the collat-
eral circulation being both a marker of CAD severity and
a predictor of future cardiac events [5]. In other words, the
positive correlation between the angiographic presence of
coronary collaterals and an unfavourable prognosis in pa-
tients with ischaemic heart disease is confounded by the
extent of CAD severity (explaining both) [110]. Therefore,
an investigation aimed at the prognostic impact of collat-
erals has to correct for the severity of the underling coron-
ary disease. On a conceptual basis, the protective effect of
the collateral circulation can hardly be refuted. A major de-
terminant of long-term survival in CAD is left ventricular
ejection fraction, the preservation of which is associated
with the coronary collateral circulation both in acute and
chronic CAD [81, 82].
With acute ischaemia, the outcome is critically dependent
on the extent of myocardial infarction, which increases
with coronary artery occlusion time and with the area at
risk for infarction, but decreases with increasing collateral
supply [7, 111, 112]. Therefore, the beneficial effect of bet-
ter developed collaterals is self-evident in acute coronary
syndrome [7]. Moreover, not only is the recovery of left
ventricular function after reperfused acute myocardial in-
farction significantly determined by the extent of collateral
supply, but it is also less dependent on time to reperfusion
in patients with sufficient collaterals [113, 114]. Further-
more, in patients with acute myocardial infarction, poor
collaterals are related to the early occurrence of cardio-
genic shock, which portends a particularly high mortality
[115]. In the context of the arrhythmogenic potential of
myocardial ischaemia, a clinical study has shown a protect-
ive effect of the collateral circulation on ischaemia-induced
QT prolongation, whereas experimental studies primarily
investigated the susceptibility to ventricular fibrillation in
acute coronary occlusion [116, 117].
With chronic ischaemia, a (further) decline in left ventricu-
lar function results from hibernating and stunned myocar-
dium [118]. Here, the not infrequently encountered case of
completely normal ventricular function in the presence of a
CTO exemplifies the protective effect of the coronary col-
lateral network (fig. 6) [24, 72]. Furthermore, it has been
shown that regional LV function is directly related to the
amount of collateral flow during both acute and chron-
ic coronary occlusion [24, 119]. Concerning postinfarction
sequelae, the relevant protective role of collaterals has been
shown to result in a reduction of postinfarct ventricular
dilatation and less ventricular aneurysm formation [7].
Regarding the impact of the coronary collateral circulation
on mortality, the majority of studies have relied on an-
giographic assessment. A recent meta-analysis included 12
angiographic studies, as well as a large study with quantit-
atively determined collateral assessment [120]. The pooled
study population consisted of more than 6,500 patients with
stable CAD, or subacute and acute myocardial infarction.
With high versus low coronary collateral circulation a sig-
nificant, 36% reduced mortality was demonstrated (fig. 7)
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[120]. Similarly, the latest follow-up (mean 7.3 ± 4.3 years)
of a large prospective cohort with chronic stable CAD and
quantitatively assessed collateral function again showed a
reduction in all-cause mortality (fig. 8), and specifically,
relevant and significant reductions in cardiac mortality and
MACE (fig. 9) with a well-functioning coronary collater-
al circulation [5]. Notably, the prediction of all-cause mor-
tality by a well-functioning coronary circulation was inde-
pendent.
Figure 6
Completely normal left ventricular angiogram (top middle and right)
due to extensive collateral supply of the proximally occluded left
anterior descending artery via apical branch and septal collateral by
the right coronary artery (bottom). Functional assessment is
performed by balloon occlusion after recanalization of the chronic
total occlusion (bottom right).
(Data from Seiler C. Assessment and impact of the human
coronary collateral circulation on myocardial ischemia and
outcome. Circ Cardiovasc Interv. 2013;6:719–28 [86], with
permission.)
Figure 7
Forest plot of risk ratios for mortality risk, stratified by type of
intervention (PCI, no PCI, and thrombolysis). CAD, coronary artery
disease; CCC, coronary collateral circulation; CI, confidence
interval; MI, myocardial infarction. Horizontal bars indicate 95%
confidence intervals.
(Data from Meier P, et al. Beneficial effect of recruitable collaterals:
a 10-year follow-up study in patients with stable coronary artery
disease undergoing quantitative collateral measurements.
Circulation. 2007;116:975–83 [40], by permission of Oxford
University Press.)
Conclusions
The coronary collateral circulation is a network of pre-
formed interarterial connections present irrespective of
coronary artery disease. Genetic determinants contribute
considerably to the wide variation in the extent of the nat-
ive collateral circulation. Stenosis severity is the single
most important environmental determinant for its enlarge-
ment in CAD. Accurate collateral assessment requires an
invasive approach, with pressure-derived CFI measure-
ments currently being the gold standard. In patients with
CAD, a well-functioning coronary collateral circulation is
independently associated with a reduction in infarct size,
left ventricular dysfunction and cardiovascular events,
which translates into a relevant improvement in survival.
Disclosures: Supported by a grant from the Swiss National
Science Foundation (to Dr Seiler), grant-#32003B-141030/1.
Figure 8
Cumulative survival rates in patients with low and with high
collateral flow index (CFI).
(Data from Seiler C, et al. Prognostic relevance of coronary
collateral function: confounded or causal relationship? Heart.
2013;99(19):1408-14 [5], with permission from BMJ Publication
Group Ltd.)
Figure 9
Cumulative survival rates related to cardiac mortality (left panel)
and to major adverse cardiac events (right panel) in patients with
low and with high collateral flow index (CFI).
(Data from Seiler C, et al. Prognostic relevance of coronary
collateral function: confounded or causal relationship? Heart.
2013;99(19):1408-14 [5], with permission from BMJ Publication
Group Ltd.)
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Figures (large format)
Figure 1
Lifecycle of the collateral circulation. The native collateral extent in the adult is determined by its formation in embryonic collaterogenesis (top
right). Blood moves to and fro in native collaterals, while effective flow is recruited by acute obstruction. With continued obstruction, there is
collateral enlargement, which occurs independent of ischaemia. Neocollateral formation has been suggested in chronic obstructive disease,
whereas experimental studies have shown collateral rarefaction with aging.
(Data from Faber JE, et al. A brief etymology of the collateral circulation. Arterioscler Thromb Vasc Biol. 2014;34:1854–9 [1], with permission.)
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Figure 2
Frequency distribution (vertical axes in percent) of collateral flow index (CFI, horizontal axes) in patients without coronary artery disease (CAD;
top left) and with increasing severity of CAD. Sufficient collaterals by CFI are present in a fourth of patients with angiographically normal
coronary arteries, whereas this proportion increases to one third in patients with CAD.
(Data from Meier P, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease
undergoing quantitative collateral measurements. Circulation. 2007;116:975–83 [40], with permission.)
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Figure 3
Frequency distribution (vertical axis in percent) of collateral flow index (CFI, horizontal axis) in 295 patients with chronic total occlusion. In this
population mean CFI was 0.39 ± 0.14.
(Adapted from van der Hoeven NW, et al. Clinical parameters associated with collateral development in patients with chronic total coronary
occlusion. Heart. 2013;99:1100–5 [38], with permission from BMJ Publishing Group Ltd.)
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Figure 4
Immersion radiography of an ex vivo arteriogram of a normal human heart. Tissue shadows are almost eliminated by immersion of the specimen
in saline. Blood vessels are radiologically demonstrated to 20 µm, a spatial resolution sufficient to reproduce the dense collateral network, over
which retrograde filling of the branch of the left circumflex coronary artery doubly ligated (arrow) before contrast injection occurs. In contrast,
coronary angiography does not detect the majority of anastomotic vessels due to its inferior spatial resolution.
(Data from Fulton WF. Immersion radiography of injected specimens. Br J Radiol. 1963;36:685–8 [121], by permission of the Oxford University
Press.)
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Figure 5
Functional collateral assessment by use of pressure-derived collateral flow index (CFI) during a 1-minute coronary balloon occlusion. Distal
occlusive pressure (Poccl, mm Hg;) is set in relation to the effective perfusion pressure, aortic pressure (Pao, mm Hg;), after correction for the
back pressure, central venous pressure (CVP, mm Hg;). Marked ST-segment elevation in the intracoronary ECG demonstrates collateral
function insufficient to prevent myocardial ischaemia at a CFI = 0.148.
(Reproduced from Seiler C, et al. Prognostic relevance of coronary collateral function: confounded or causal relationship? Heart.
2013;99(19):1408-14 [5], with permission from BMJ Publication Group Ltd.)
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Figure 6
Completely normal left ventricular angiogram (top middle and right) due to extensive collateral supply of the proximally occluded left anterior
descending artery via apical branch and septal collateral by the right coronary artery (bottom). Functional assessment is performed by balloon
occlusion after recanalization of the chronic total occlusion (bottom right).
(Data from Seiler C. Assessment and impact of the human coronary collateral circulation on myocardial ischemia and outcome. Circ Cardiovasc
Interv. 2013;6:719–28 [86], with permission.)
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Figure 7
Forest plot of risk ratios for mortality risk, stratified by type of intervention (PCI, no PCI, and thrombolysis). CAD, coronary artery disease; CCC,
coronary collateral circulation; CI, confidence interval; MI, myocardial infarction. Horizontal bars indicate 95% confidence intervals.
(Data from Meier P, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease
undergoing quantitative collateral measurements. Circulation. 2007;116:975–83 [40], by permission of Oxford University Press.)
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Figure 8
Cumulative survival rates in patients with low and with high collateral flow index (CFI).
(Data from Seiler C, et al. Prognostic relevance of coronary collateral function: confounded or causal relationship? Heart. 2013;99(19):1408-14
[5], with permission from BMJ Publication Group Ltd.)
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Figure 9
Cumulative survival rates related to cardiac mortality (left panel) and to major adverse cardiac events (right panel) in patients with low and with
high collateral flow index (CFI).
(Data from Seiler C, et al. Prognostic relevance of coronary collateral function: confounded or causal relationship? Heart. 2013;99(19):1408-14
[5], with permission from BMJ Publication Group Ltd.)
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